Tracking tumor biology in real time: circulating tumor cells in laryngopharyngeal carcinoma

Background Laryngopharyngeal squamous cell carcinoma (LPSCC), a subset of head and neck malignancies, reveals different clinical outcomes despite similar staging. Circulating tumor cells (CTCs) have emerged as one of the important and promising minimally invasive biomarkers for disease management; however, their clinical utility in LPSCC remains unclear, particularly in resource-limited settings. Methods This prospective observational study was conducted at the State Cancer Institute, a part of a tertiary cancer hospital center in the northernmost region of India, from June 2021 to March 2026. Peripheral blood samples were collected at baseline (n=30) and at 3-month follow-up. The 3-month interval was chosen to assess short-term changes in the study parameters. All enrolled subjects continue to remain under follow-up beyond this period, and data collection is ongoing to capture longer-term outcomes. CTCs were detected and quantified using an EpCAM-based enrichment method with immunofluorescence markers. Associations between CTC counts, clinicopathological variables, treatment response, and disease outcomes were analyzed. Results Baseline CTCs were detected in 53% of patients, with the majority of the demographic and clinical variables showing insignificant associations with CTC positivity (all P >0.05). At 3 months, 94% of evaluable patients achieved a complete response, while CTC progression was noted in 56% (9/16). P = 0.049). CTC dynamics did not correlate significantly with treatment response or survival outcomes. Nodal involvement, rather than CTC burden, emerged as a stronger predictor of prognosis. At 3 years, overall survival (OS) was 69.0% for the cohort, with no significant difference by CTC status (76.9% vs. 62.5%, P = 0.507); however, nodal involvement was strongly associated with poorer OS (90.0% vs. 22.2%, P = 0.0001). Cancer-specific OS at 3 years was 81.2%, with significantly worse outcomes in patients with CTCs, 68.8% vs. 100% ( P = 0.049). Conclusion CTCs were detectable across both early and locally advanced LPSCC. Although dynamic changes in CTCs were noted, their prognostic significance remains unclear. Larger longitudinal studies are required to validate CTCs as biomarkers and to explore their role in personalized management of LPSCC.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-12
DOI
https://doi.org/10.3389/fonc.2026.1968754
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tracking tumor biology in real time: circulating tumor cells in laryngopharyngeal carcinoma

Nazir Ahmad Dar, Malik Tariq Rasool, Saquib Zaffar Banday, Aaqib Zaffar Banday et al.
Frontiers in Oncology
Head and Neck Cancer Studies
article

Tracking tumor biology in real time: circulating tumor cells in laryngopharyngeal carcinoma

Nazir Ahmad Dar, Malik Tariq Rasool, Saquib Zaffar Banday, Aaqib Zaffar Banday, Musaib Mushtaq, G. A. Bhat, Kaneez Fatima, Zaffar Amin Shah, Jasirah Idris Wani
article en

Abstract

Background Laryngopharyngeal squamous cell carcinoma (LPSCC), a subset of head and neck malignancies, reveals different clinical outcomes despite similar staging. Circulating tumor cells (CTCs) have emerged as one of the important and promising minimally invasive biomarkers for disease management; however, their clinical utility in LPSCC remains unclear, particularly in resource-limited settings. Methods This prospective observational study was conducted at the State Cancer Institute, a part of a tertiary cancer hospital center in the northernmost region of India, from June 2021 to March 2026. Peripheral blood samples were collected at baseline (n=30) and at 3-month follow-up. The 3-month interval was chosen to assess short-term changes in the study parameters. All enrolled subjects continue to remain under follow-up beyond this period, and data collection is ongoing to capture longer-term outcomes. CTCs were detected and quantified using an EpCAM-based enrichment method with immunofluorescence markers. Associations between CTC counts, clinicopathological variables, treatment response, and disease outcomes were analyzed. Results Baseline CTCs were detected in 53% of patients, with the majority of the demographic and clinical variables showing insignificant associations with CTC positivity (all P >0.05). At 3 months, 94% of evaluable patients achieved a complete response, while CTC progression was noted in 56% (9/16). P = 0.049). CTC dynamics did not correlate significantly with treatment response or survival outcomes. Nodal involvement, rather than CTC burden, emerged as a stronger predictor of prognosis. At 3 years, overall survival (OS) was 69.0% for the cohort, with no significant difference by CTC status (76.9% vs. 62.5%, P = 0.507); however, nodal involvement was strongly associated with poorer OS (90.0% vs. 22.2%, P = 0.0001). Cancer-specific OS at 3 years was 81.2%, with significantly worse outcomes in patients with CTCs, 68.8% vs. 100% ( P = 0.049). Conclusion CTCs were detectable across both early and locally advanced LPSCC. Although dynamic changes in CTCs were noted, their prognostic significance remains unclear. Larger longitudinal studies are required to validate CTCs as biomarkers and to explore their role in personalized management of LPSCC.

Frontiers in OncologyVol. 16
Government Medical College (IN), Sher-i-Kashmir Institute of Medical Sciences (IN), Paras Hospitals (IN)
Good health and well-being
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon